, Tracking Stock Market Picks
Enter Symbol:
Solta Medical Inc (SLTM) [hlAlert]

up 20.16 %

Solta Medical Inc (SLTM) rated Buy with price target $5.25 by MDB Capital Group

Posted on: Tuesday,  May 11, 2010  8:25 AM ET by MDB Capital Group

MDB Capital Group rated Buy Solta Medical Inc (NASDAQ: SLTM) on 05/11/2010, when the stock price was $2.43.
Since then, Solta Medical Inc has gained 20.16% as of 01/22/2014's recent price of $2.92.
If you would have followed this MDB Capital Group's recommendation on SLTM, you would have gained 20.16% of your investment in 1352 days.

Solta Medical Inc., formerly Thermage, Inc. is engaged in designing, developing, manufacturing and marketing energy-based medical device systems for aesthetic applications. These systems are marketed under the brand names Fraxel and Thermage and are Food & Drug Administration (FDA) cleared for dermatological procedures in the applications, which include: Skin Tightening, the Thermage NXT system offers non-invasive treatment options for skin tightening and contouring, body shaping, and improvement in the appearance of cellulite; Skin Rejuvenation, the Fraxel re:fine and Fraxel re:store systems offer treatments for skin conditions such as fine lines and pigmentation.

MDB Capital has strives to be the leading micro-cap research firm. Our focus is on companies between $40-$200MM in market capitalization that are not widely covered by other research firms. Our objective in following this sector is to provide our investors with idea that lead to above markets returns. MDB strives to provide insightful, independent and performance-oriented research. We strictly maintain a pure research environment, where solid research opinions are formed by our analysts' thorough evaluations, rather than influenced by investment banking relationships.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/11/2010 8:25 AM Buy
2.43 5.25
as of 12/31/2010
1 Week down  -12.75 %
1 Month up  28.07 %
3 Months up  30.00 %
1 YTD up  6.99 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy